Allen Ho

Allen Ho currently serves as the National Director of Field Medical for Ultra-Rare Medicines at Amgen, a position held since October 2023. Prior to this role, Allen Ho was with Alexion Pharmaceuticals, Inc. from April 2018 to September 2023, holding titles of Director, MSL Lead in Hematology/Nephrology, as well as Senior Medical Science Liaison in the same therapeutic areas. Allen Ho's earlier experience includes a tenure at Astellas Pharma US from 2009 to 2018, where roles included Senior Manager and Medical Science Liaison in Infectious Disease-Transplant. Allen Ho began a Post-Doctoral Fellowship at Rutgers University in July 2008, focusing on market research and competitive intelligence with Tibotec Therapeutics while also serving as Adjunct Faculty. Allen Ho earned a Doctor of Pharmacy degree (Pharm.D.) from the University of the Pacific between 2005 and 2008.